Cookie Hinweis

Wir verwenden Cookies, um Ihnen ein optimales Webseiten-Erlebnis zu bieten. Dazu zählen Cookies, die für den Betrieb der Seite notwendig sind, sowie solche, die lediglich zu anonymen Statistikzwecken, für Komforteinstellungen oder zur Anzeige personalisierter Inhalte genutzt werden. Sie können selbst entscheiden, welche Kategorien Sie zulassen möchten. Bitte beachten Sie, dass auf Basis Ihrer Einstellungen womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen. Weitere Informationen finden Sie in unseren Datenschutzhinweisen .

Essentiell

Diese Cookies sind für die Funktionalität unserer Website erforderlich und können nicht deaktiviert werden.

Name Webedition CMS
Zweck Dieses Cookie wird vom CMS (Content Management System) Webedition für die unverwechselbare Identifizierung eines Anwenders gesetzt. Es bietet dem Anwender bessere Bedienerführung, z.B. Speicherung von Sucheinstellungen oder Formulardaten. Typischerweise wird dieses Cookie beim Schließen des Browsers gelöscht.
Name econda
Zweck Session-Cookie für die Webanalyse Software econda. Diese läuft im Modus „Anonymisiertes Messen“.
Statistik

Diese Cookies helfen uns zu verstehen, wie Besucher mit unserer Webseite interagieren, indem Informationen anonym gesammelt und analysiert werden. Je nach Tool werden ein oder mehrere Cookies des Anbieters gesetzt.

Name econda
Zweck Measure with Visitor Cookie emos_jcvid
Externe Medien

Inhalte von Videoplattformen werden standardmäßig blockiert. Wenn Cookies von externen Medien akzeptiert werden, bedarf der Zugriff auf diese Inhalte keiner manuellen Zustimmung mehr.

Name Youtube
Zweck Externe Medien

Publikationen

1. Dos Santos José Carlos, Beijer Barbro, Bauder-Wüst Ulrike*, Schäfer Martin*, Leotta Karin, Eder Matthias*, Benešová Martina*, Kleist Christian, Giesel Frederic, Kratochwil Clemens, Kopka Klaus*, Haberkorn Uwe*, Mier Walter: Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes. Journal of nuclear medicine 2020, 61:70-79.

2. Farolfi Andrea*, Ilhan Harun, Gafita Andrei, Calais Jeremie, Barbato Francesco*, Weber Manuel*, Afshar-Oromieh Ali, Spohn Fabian, Wetter Axel, Rischpler Christoph*, Hadaschik Boris, Pianori Davide, Fanti Stefano, Haberkorn Uwe*, Eiber Matthias, Herrmann Ken*, Fendler Wolfgang Peter*: Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET. Journal of nuclear medicine 2020, 61:1037 - 1042.

3. Giannoula E., Panagiotidis E., Katsikavelas I., Chatzipavlidou V., Sachpekidis C.*, Bamidis P., Raftopoulos V., Iakovou I.: Quality & safety aspects of nuclear medicine practice: Definitions and review of the current literature. Hellenic journal of nuclear medicine 2020, 23:60-66.

4. Grossner Tobias, Haberkorn Uwe*, Gotterbarm Tobias: 18F- based Quantification of the Osteogenic Potential of hMSCs. International journal of molecular sciences 2020, 21:7692.

5. Haberkorn Uwe*, Kratochwil Clemens, Giesel Frederik: Internal Radiation Therapy. Recent results in cancer research 2020, 216:881-902.

6. Halama Niels*, Haberkorn Uwe*: The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors. Seminars in nuclear medicine 2020, 50:389-398.

7. Haupt Fabian, Dijkstra Lotte, Alberts Ian, Sachpekidis Christos, Fech Viktor, Boxler Silvan, Gross Tobias, Holland-Letz Tim*, Zacho Helle D, Haberkorn Uwe*, Rahbar Kambiz, Rominger Axel, Afshar-Oromieh Ali: 68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol. European Journal of nuclear medicine and molecular imaging 2020, 47:624-631.

8. Heckmann Markus B, Reinhardt Finn, Finke Daniel, Katus Hugo A, Haberkorn Uwe*, Leuschner Florian, Lehmann Lorenz*: Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease. Circulation / Cardiovascular imaging 2020, 13:e010628.

9. Iakovou Ioannis, Giannoula Evanthia, Chatzipavlidou Vasiliki, Sachpekidis Christos*: Associating radioiodine therapy in hyperthyroidism with cancer mortality: robust or random results of a statistical analysis? Hellenic journal of nuclear medicine 2020, 23:94-95.

10. Iakovou Ioannis, Giannoula Evanthia, Sachpekidis Christos*: Imaging and Imaging-Based Management of Pediatric Thyroid Nodules. Journal of Clinical Medicine 2020, 9:384.

11. Iakovou Ioannis, Symeonidis Panagiotis, Kotrotsios Dimitrios, Giannoula Evanthia, Sachpekidis Christos*: Radiosynoviorthesis after Surgery in the Treatment of Patients with Ankle Pigmented Villonodular Synovitis: A Case Series. Journal of Clinical Medicine 2020, 9:597.

12. Khreish Fadi, Rosar Florian, Kratochwil Clemens, Giesel Frederik Lars, Haberkorn Uwe*, Ezziddin Samer: Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease. European journal of nuclear medicine and molecular imaging 2020, 47:2040-2041.

13. Kim James*, Novak Daniel*, Sachpekidis Christos*, Utikal Jochen*, Larribère Lionel*: STAT3 Relays a Differential Response to Melanoma-Associated NRAS Mutations. Cancers 2020, 12:119.

14. Koerber Stefan A, Stach Gerald, Kratochwil Clemens, Haefner Matthias F, Rathke Henrik, Herfarth Klaus, Kopka Klaus*, Holland-Letz Tim*, Choyke Peter L, Will Leon, Haberkorn Uwe*, Debus Juergen*, Giesel Frederik*: Lymph node involvement in treatment-naïve prostate cancer patients - correlation of PSMA-PET/CT imaging and Roach formula in 280 men in the Radiotherapeutic management. Journal of nuclear medicine 2020, 61:46-50.

15. Koerber Stefan A, Staudinger Fabian, Kratochwil Clemens*, Adeberg Sebastian, Haefner Matthias F, Ungerechts Guy, Rathke Hendrik, Winter Erik, Lindner Thomas, Syed Mustafa, Bhatti Irfan A, Herfarth Klaus, Choyke Peter L, Jaeger Dirk, Haberkorn Uwe*, Debus Juergen*, Giesel Frederik*: The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience. Journal of nuclear medicine 2020, 61:1331 - 1336.

16. Koralli Panagiota*, D. Negka Alkmini*, Vagiaki Lida Evmorfia, Pavlou Aristea, Siskos Michael G., Dimitrakopoulou-Strauss Antonia*, Gregoriou Vasilis G., Chochos Christos L.: New conjugated polymer nanoparticles with high photoluminescence quantum yields for far-red and near infrared fluorescence bioimaging. Materials chemistry frontiers 2020, 4:2357 - 2369.

17. Kratochwil Clemens, Giesel Frederik L, Heussel Claus-Peter, Kazdal Daniel, Endris Volker, Nientiedt Cathleen, Bruchertseifer Frank, Kippenberger Maximilian, Rathke Hendrik, Leichsenring Jonas, Hohenfellner Markus, Morgenstern Alfred, Haberkorn Uwe*, Duensing Stefan, Stenzinger Albrecht: Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated Genes. Journal of nuclear medicine 2020, 61:683 - 688.

18. Kratochwil Clemens, Haberkorn Uwe*, Giesel Frederik Lars: 225Ac-PSMA-617 for Therapy of Prostate Cancer. Seminars in nuclear medicine 2020, 50:133 - 140.

19. Lindner Thomas, Altmann Annette*, Krämer Susanne, Kleist Christian, Loktev Anastasia*, Kratochwil Clemens, Giesel Frederik, Mier Walter, Marme Frederik, Debus Jürgen*, Haberkorn Uwe*: Design and Development of 99m Tc-Labeled FAPI Tracers for SPECT Imaging and 188 Re Therapy. Journal of nuclear medicine 2020, 61:1507 - 1513.

20. Meyer Catherine, Dahlbom Magnus, Lindner Thomas, Vauclin Sebastien, Mona Christine, Slavik Roger, Czernin Johannes*, Haberkorn Uwe*, Calais Jeremie: Radiation Dosimetry and Biodistribution of 68 Ga-FAPI-46 PET Imaging in Cancer Patients. Journal of nuclear medicine 2020, 61:1171 - 1177.

21. Mühlberg Eric, Umstätter Florian, Domhan Cornelius, Hertlein Tobias, Ohlsen Knut, Krause Andreas, Kleist Christian, Beijer Barbro, Zimmermann Stefan, Haberkorn Uwe*, Mier Walter, Uhl Philipp: Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci. Pharmaceuticals 2020, 13:110

22. Nientiedt Cathleen, Endris Volker, Jenzer Maximilian, Mansour Josef, Sedehi Nassim Tawanaie Pour, Pecqueux Carine, Volckmar Anna-Lena, Leichsenring Jonas, Neumann Olaf, Kirchner Martina, Hoveida Shirin, Lantwin Philippa, Kaltenecker Katrin, Dieffenbacher Svenja, Gasch Claudia, Hofer Luisa, Franke Desiree, Tosev Georgi, Görtz Magdalena, Schütz Viktoria, Radtke Jan-Philipp, Nyarangi-Dix Joanne, Hatiboglu Gencay, Simpfendörfer Tobias, Schönberg Gita, Isaac Sanjay, Teber Dogu, Koerber Stefan A, Christofi Georgia, Czink Elena, Kreuter Rebecca, Apostolidis Leonidas, Kratochwil Clemens*, Giesel Frederik*, Haberkorn Uwe*, Debus Jürgen, Sültmann Holger*, Zschäbitz Stefanie, Jäger Dirk, Duensing Anette, Schirmacher Peter, Grüllich Carsten, Hohenfellner Markus, Stenzinger Albrecht, Duensing Stefan: High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel. Urologic oncology 2020, 38:637.e617-637.e627.

23. Petersen Lars J, Nielsen Julie B, Langkilde Niels C, Petersen Astrid, Afshar-Oromieh Ali, De Souza Nandita M, De Paepe Katja, Fisker Rune V, Arp Dennis T, Carl Jesper, Haberkorn Uwe*, Zacho Helle D: 68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study. World journal of urology 2020, 38:939-948.

24. Rathke Hendrik, Holland-Letz Tim*, Mier Walter, Flechsig Paul, Mavriopoulou Eleni, Röhrich Manuel, Kopka Klaus*, Hohenfellner Markus, Giesel Frederik L, Haberkorn Uwe A*, Kratochwil Clemens: Response prediction of 177Lu-PSMA-617 RLT using PSA, Chromogranin A, and LDH. Journal of nuclear medicine 2020, 61:689-695.

25. Ristau J.*, Giesel F. L.*, Haefner M. F.*, Staudinger F., Lindner T., Merkel A., Schlittenhardt J., Kratochwil C.*, Choyke P. L., Herfarth K.*, Debus J.*, Haberkorn U.*, Koerber S. A.*: Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer. Molecular imaging & biology 2020, 22:1495-1500.

26. Röhrich Manuel*, Floca Ralf*, Loi Lisa*, Adeberg Sebastian, Windisch Paul, Giesel Frederik L, Kratochwil Clemens, Flechsig Paul, Rathke Hendrik, Lindner Thomas*, Loktev Anastasia*, Schlemmer Heinz Peter*, Haberkorn Uwe*, Paech Daniel*: FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas. European journal of radiology 2020, 127:109021.

27. Röhrich Manuel*, Loi Lisa*, Floca Ralf*, Haberkorn Uwe*, Paech Daniel*: Dataset of voxelwise correlated signal values of ADC, rCBV and FAP-specific PET of 13 Glioblastoma patients. Data in Brief 2020, 31:105712.

28. Sachpekidis Christos*, Afshar-Oromieh A., Kopka K.*, Strauss D. S.*, Pan Leyun*, Haberkorn U.*, Dimitrakopoulou-Strauss Antonia*: 18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer. European journal of nuclear medicine and molecular imaging 2020, 47:592-602.

29. Sachpekidis Christos*, Exadaktylou Paraskevi, Katsampoukas Dimitrios, Moralidis Efstratios, Arsos Georgios: 18F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan. Hellenic journal of nuclear medicine 2020, 23:76-78.

30. Sachpekidis Christos*, Kopp-Schneider Annette*, Merz Maximilian, Jauch Anna, Raab Marc-Steffen, Goldschmidt Hartmut, Dimitrakopoulou-Strauss Antonia*: Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma? Cancers 2020, 12:1335.

31. Sachpekidis Christos*, Sidiropoulou Polytimi, Hassel Jessica C, Drakoulis Nikolaos, Dimitrakopoulou-Strauss Antonia*: Positron Emission Tomography in Merkel Cell Carcinoma. Cancers 2020, 12:2897.

32. Salzmann Martin, Benesova Karolina, Buder-Bakhaya Kristina, Papamichail Dimitrios*, Dimitrakopoulou-Strauss Antonia*, Lorenz Hanns-Martin, Enk Alexander H, Hassel Jessica C: Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients. Cancers 2020, 12:3004.

33. Sauter Max, Strieker Matthias, Kleist Christian, Wischnjow Artjom, Daniel Volker, Altmann Annette*, Haberkorn Uwe*, Mier Walter: Improving antibody-based-therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery. Journal of controlled release 2020, 322:200-208.

34. Schaefer Anne, Sachpekidis Christos*, Diella Francesca, Doerks Anja, Kratz Anne-Sophie, Meisel Christian, Jackson David B, Soldatos Theodoros G: Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients. Cancers 2020, 12:1008.

35. Scherer Jonas*, Nolden Marco*, Kleesiek Jens*, Metzger Jasmin*, Kades Klaus*, Schneider Verena*, Bach Michael*, Sedlaczek Oliver*, Bucher Andreas M*, Vogl Thomas J*, Grünwald Frank*, Kühn Jens-Peter*, Hoffmann Ralf-Thorsten*, Kotzerke Jörg*, Bethge Oliver*, Schimmöller Lars*, Antoch Gerald*, Müller Hans-Wilhelm*, Daul Andreas*, Nikolaou Konstantin*, la Fougère Christian*, Kunz Wolfgang G*, Ingrisch Michael*, Schachtner Balthasar*, Ricke Jens*, Bartenstein Peter*, Nensa Felix*, Radbruch Alexander*, Umutlu Lale*, Forsting Michael*, Seifert Robert*, Herrmann Ken*, Mayer Philipp*, Kauczor Hans-Ulrich*, Penzkofer Tobias*, Hamm Bernd*, Brenner Winfried*, Kloeckner Roman*, Düber Christoph*, Schreckenberger Mathias*, Braren Rickmer*, Kaissis Georgios*, Makowski Marcus*, Eiber Matthias*, Gafita Andrei*, Trager Rupert*, Weber Wolfgang A*, Neubauer Jakob*, Reisert Marco*, Bock Michael*, Bamberg Fabian*, Hennig Jürgen*, Meyer Philipp Tobias*, Ruf Juri*, Haberkorn Uwe*, Schoenberg Stefan O*, Kuder Tristan Anselm*, Neher Peter*, Floca Ralf Omar*, Schlemmer Heinz-Peter*, Maier-Hein Klaus*: Joint Imaging Platform for Federated Clinical Data Analytics. JCO clinical cancer informatics 2020, 4:1027 - 1038.

36. Shinya Takayoshi, Otomi Yoichi, Dimitrakopoulou-Strauss Antonia*, Kubo Michiko, Kondo Mihoko, Otomo Maki, Terazawa Kaori, Bando Yoshimi, Harada Masafumi: Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin's lymphoma: a prospective study. Nuclear medicine communications 2020, 41:26 - 33.

37. Syed M., Flechsig P., Liermann J., Windisch P., Staudinger F., Akbaba S., Koerber S. A., Freudlsperger C., Plinkert P. K., Debus J.*, Giesel F., Haberkorn U.*, Adeberg S.: Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers. European journal of nuclear medicine and molecular imaging 2020, 47:2836-2845.

38. Umstätter Florian, Domhan Cornelius, Hertlein Tobias, Ohlsen Knut, Mühlberg Eric, Kleist Christian, Zimmermann Stefan, Beijer Barbro, Klika Karel D*, Haberkorn Uwe*, Mier Walter, Uhl Philipp: Vancomycin Resistance is Overcome by Conjugation of Polycationic Peptides. Angewandte Chemie / International edition International edition 2020, 59:8823-8827.

39. Windisch Paul, Röhrich Manuel, Regnery Sebastian, Tonndorf-Martini Eric, Held Thomas, Lang Kristin, Bernhardt Denise, Rieken Stefan, Giesel Frederik, Haberkorn Uwe*, Debus Jürgen*, Adeberg Sebastian*: Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma. Radiotherapy and oncology 2020, 150:159 - 163.

40. Windisch Paul, Zwahlen Daniel R, Koerber Stefan A*, Giesel Frederik L, Debus Jürgen*, Haberkorn Uwe*, Adeberg Sebastian*: Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review. Cancers 2020, 12:2629.

41. Zippel Claus, Ronski Sarah C, Bohnet-Joschko Sabine, Giesel Frederik L*, Kopka Klaus*: Current Status of PSMA-Radiotracers for Prostate Cancer: Data Analysis of Prospective Trials Listed on ClinicalTrials.gov. Pharmaceuticals 2020, 13:12.

nach oben
powered by webEdition CMS